Exclusive

Publication

Byline

Location

US Patent Issued to Acura Pharmaceuticals on Sept. 22 for "Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse" (Indiana Inventor)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,948, issued on Sept. 22, was assigned to Acura Pharmaceuticals Inc. (Palatine, Ill.). "Methods and compositions for interfering with extra... Read More


US Patent Issued to ANTECIP BIOVENTURES II on Sept. 22 for "Treatment of agitation associated with Alzheimer's disease with a combination of bupropion and dextromethorphan" (New York Inventor)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,949, issued on Sept. 22, was assigned to ANTECIP BIOVENTURES II LLC (New York). "Treatment of agitation associated with Alzheimer's diseas... Read More


US Patent Issued to The Regents of The University of California, Nanyang Technological University, National University of Singapore on Sept. 22 for "Short conjugated oligoelectrolytesand antibiotics" (Singaporean, American Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,950, issued on Sept. 22, was assigned to The Regents of The University of California (Oakland, Calif.), Nanyang Technological University (S... Read More


US Patent Issued to Amneal Complex Products Research on Sept. 22 for "Delayed release compositions" (New Jersey Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,951, issued on Sept. 22, was assigned to Amneal Complex Products Research LLC (Bridgewater, N.J.). "Delayed release compositions" was inve... Read More


US Patent Issued to Gongwin Biopharm on Sept. 22 for "Benzenesulfonamide derivatives and method for modulating lipid raft" (Taiwanese, Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,952, issued on Sept. 22, was assigned to Gongwin Biopharm Co. Ltd. (Taipei City, Taiwan). "Benzenesulfonamide derivatives and method for m... Read More


US Patent Issued to The Regents of the University of California on Sept. 22 for "Compositions comprising HDAC inhibitors and retinoids" (California Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,953, issued on Sept. 22, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions comprising HDAC inhi... Read More


US Patent Issued to United Therapeutics on Sept. 22 for "Treatment for interstitial lung disease" (North Carolina Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,954, issued on Sept. 22, was assigned to United Therapeutics Corp. (Silver Spring, Md.). "Treatment for interstitial lung disease" was inv... Read More


US Patent Issued to Cambridge Enterprise on Sept. 22 for "Treatment or prevention of ischaemic stroke reperfusion injury" (British Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,955, issued on Sept. 22, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain). "Treatment or prevention of ischaemic strok... Read More


US Patent Issued to PHARMA FOODS INTERNATIONAL, KYOTO PREFECTURAL PUBLIC UNIVERSITY on Sept. 22 for "GABA-containing composition" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,956, issued on Sept. 22, was assigned to PHARMA FOODS INTERNATIONAL Co. LTD. (Kyoto, Japan) and KYOTO PREFECTURAL PUBLIC UNIVERSITY Corp. (... Read More


US Patent Issued on Sept. 22 for "Composition and method to reduce liver fat and circulating triacylglycerols" (Colorado, California, Connecticut Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,740,957, issued on Sept. 22. "Composition and method to reduce liver fat and circulating triacylglycerols" was invented by Robert R. Wolfe (No... Read More